Search - tctmd.com

Displaying 361 - 380 of 576

Sort: Relevancy | Date

Presentation TVT 2016

Access Site Management Strategies, Including New Large-Hole Closure Devices - 2

Presenter: Alexandre Abizaid

June 17, 2016

Presentation TVT 2016

Access Site Management Strategies, Including New Large-Hole Closure Devices - 1

Presenter: Nicolas M. Van Mieghem

June 17, 2016

Presentation TVT 2016

Left Main Coronary Disease and AS: Management Approaches With Case Examples

Presenter: Raj Makkar

June 17, 2016

Presentation TVT 2016

The Bard TRUE Balloon: Design Features and Clinical Applications

Presenter: Jeffrey J. Popma

June 17, 2016

Presentation TVT 2016

Severe Chronic Kidney Disease and TAVR: Clinical Management Recommendations

Presenter: Ganesh Manoharan

June 17, 2016

Presentation TVT 2016

Replacing the Valve Is Usually Sufficient to Manage Severe AS and Coronary Disease

Presenter: Mark J. Russo

June 17, 2016

Presentation TVT 2016

The InterValve V8 Balloon: Design Features and Clinical Applications

Presenter: Wesley R. Pedersen

June 17, 2016

Presentation TVT 2016

Anatomy of Low Coronary Artery Height

Presenter: Creighton W. Don

June 17, 2016

Presentation TVT 2016

STATE-OF-THE-ART LECTURE: Balloon Aortic Valvuloplasty in 2016 Equipment, Optimal Procedural Techniques, and Clinical Outcomes

Presenter: Helene Eltchaninoff

June 17, 2016

Presentation TVT 2016

Anatomical Pearls of the Aortic Valve Complex: Session Introduction

Presenter: James M. McCabe

June 17, 2016

News Conference News TVT 2016

To Intervene or Not to Intervene When the TAVR Patient Has CAD: New Insights

Shelley Wood

June 17, 2016

Presentation TVT 2016

TVT 1074: Left Main Obstruction During TAVR With Lotus Valve

Presenter: Marek Grygier, MD

June 16, 2016

Presentation CCVVC 2016

Subclinical Leaflet Thrombosis Post-TAVR

Presenter: Gian Paolo Ussia

June 16, 2016

Presentation TVT 2016

TVT 1060: Transcaval TAVR With Simultaneous Impella-Assisted Left-Main PCI

Presenter: Ateet Patel, MD

June 16, 2016

Presentation TVT 2016

The Natural History of Leaflet Thrombosis and Abnormal Motion in Aortic Bioprosthetic Valves

Presenter: Lars Sondergaard

June 16, 2016

Presentation TVT 2016

The Case for and Against Cerebral Embolic Protection During TAVR

Presenter: Susheel Kodali

June 16, 2016

News Opinion Editor's Corner

TCTMD’s Top 10 Most Popular Stories for May 2016

Shelley Wood

May 31, 2016

News Conference News EuroPCR 2016

Studies Highlight Permanent Pacemaker Rates Among New-Generation TAVR Devices

Michael O'Riordan

May 23, 2016

Presentation EuroPCR 2016

A Patient Level Pooled Analysis of NeuroProtection with the TriGuard Embolic DEFLECTion Device Compared to Unprotected Transcatheter Aortic Valve Replacement

Presenter: Alexandra Lansky

May 20, 2016

News Conference News EuroPCR 2016

‘Obesity Paradox’ Alive, Well, and Mysterious After TAVR

Yael L. Maxwell

May 18, 2016

Advertisement

Access Site Management Strategies, Including New Large-Hole Closure Devices - 2

Access Site Management Strategies, Including New Large-Hole Closure Devices - 1

Left Main Coronary Disease and AS: Management Approaches With Case Examples

The Bard TRUE Balloon: Design Features and Clinical Applications

Severe Chronic Kidney Disease and TAVR: Clinical Management Recommendations

Replacing the Valve Is Usually Sufficient to Manage Severe AS and Coronary Disease

The InterValve V8 Balloon: Design Features and Clinical Applications

Anatomy of Low Coronary Artery Height

STATE-OF-THE-ART LECTURE: Balloon Aortic Valvuloplasty in 2016 Equipment, Optimal Procedural Techniques, and Clinical Outcomes

Anatomical Pearls of the Aortic Valve Complex: Session Introduction

To Intervene or Not to Intervene When the TAVR Patient Has CAD: New Insights

TVT 1074: Left Main Obstruction During TAVR With Lotus Valve

Subclinical Leaflet Thrombosis Post-TAVR

TVT 1060: Transcaval TAVR With Simultaneous Impella-Assisted Left-Main PCI

The Natural History of Leaflet Thrombosis and Abnormal Motion in Aortic Bioprosthetic Valves

The Case for and Against Cerebral Embolic Protection During TAVR

TCTMD’s Top 10 Most Popular Stories for May 2016

Studies Highlight Permanent Pacemaker Rates Among New-Generation TAVR Devices

A Patient Level Pooled Analysis of NeuroProtection with the TriGuard Embolic DEFLECTion Device Compared to Unprotected Transcatheter Aortic Valve Replacement

‘Obesity Paradox’ Alive, Well, and Mysterious After TAVR

Advertisement

Advertisement

Sign In

Forgot Your Password?

Search TCTMD

CME TITLE

Sign up for our newsletter

Search TCTMD

Submit an Event

Become a PREMIUM MEMBER or LOG IN to view exclusive content

REGISTER for free or LOG IN to view this content